KR Südkorea
  • 30 - Pharmazeutische Erzeugnisse


Amendment of "Pharmaceutical Affairs Act" (8 page(s), in Korean)

To ensure safety management system for pharmaceuticals by preparing legal framework to implement remote inspections of foreign pharmaceutical manufacturers-importers when the on-site inspections are not possible in a situation like Covid-19 pandemic.

To clarify where the responsibility lies for deliberation of pharmaceutical side effect to provide penalties by creating legal fiction as public officials, if members in Deliberative Council on Side Effects of Drugs, who are not public officials, violate criminal law such as releasing secret information, requesting-accepting bribe and arbitrarily arranging deliberation.